Esther Martinborough
Patrimonio netto: 291 621 $ in data 30/06/2026
Patrimonio netto: 291 621 $ in data 30/06/2026
Esther Martinborough is currently an Independent Director at Codexis, Inc. since 2021 and a Director at San Diego Squared since 2021.
Former positions include Chief Scientific Officer at Escient Pharmaceuticals, Inc. from 2023 to 2024 and Executive Director-Research at Receptos LLC from 2015 to 2018.
Education includes a doctorate from the Swiss Federal Institute of Technology and graduate studies at the University of California.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CODEXIS, INC. 0,14% | 17/06/2026 | 129.036 ( 0,14% ) | 291 621 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CODEXIS, INC. | Direttore/Membro del Consiglio | 02/02/2021 |
| Società | Posizione | Fine |
|---|---|---|
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Direttore Tecnico/Scientifico/R&S | 01/05/2024 |
| RECEPTOS INC | Direttore/Membro del Consiglio | 01/01/2015 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Codexis, Inc.
Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
Receptos LLC
Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale